Insider · CIK 0001247015

BARER SOL J

Reports to the SEC for 11 companies · TEL AVIV

sec.gov

Transactions

Companies

Filings

CIK

0001247015

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Director	MExercise/Conversion	+21.7K sh	—	—	448,011
2026-06-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−21.7K sh	—	—	0
2026-05-28	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	Director	AAward	+10.9K sh	—	—	10,863
2025-06-06	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Director	MExercise/Conversion	+17.2K sh	—	—	426,272
2025-06-06	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−17.2K sh	—	—	0
2025-06-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	Director	AAward	+21.7K sh	—	—	21,739
2024-06-15	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−37.6K sh	—	—	0
2024-06-15	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Director	MExercise/Conversion	+37.6K sh	—	—	409,114
2024-06-06	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	Director	AAward	+17.2K sh	—	—	17,158
2023-08-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−28.2K sh	—	—	0
2023-08-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Director	MExercise/Conversion	+28.2K sh	—	—	371,516
2023-07-05	NexImmune, Inc.Stock Option (right to buy)A Award	Director	AAward	+45K sh	—	—	44,983
2023-06-15	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	Director	AAward	+37.6K sh	—	—	37,598
2023-04-04	NexImmune, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−61.7K sh	—	—	0
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Director	AAward	+19.1K sh	—	—	19,113
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Director	AAward	+61.7K sh	—	—	61,678
2023-04-04	NexImmune, Inc.Stock Option (right to buy)A Award	Director	AAward	+156K sh	—	—	155,900
2023-04-04	NexImmune, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−156K sh	—	—	0
2023-04-04	NexImmune, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−19.1K sh	—	—	0
2023-03-30	NexImmune, Inc.P Purchase	Director	PPurchase	+400K sh	$0.41	+$164K	2,217,814
2022-11-17	NexImmune, Inc.P Purchase	Director	PPurchase	+75K sh	$0.48	+$35.9K	1,817,814
2022-11-16	NexImmune, Inc.P Purchase	Director	PPurchase	+125K sh	$0.48	+$60.3K	1,742,814
2022-08-04	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	Director	AAward	+28.2K sh	—	—	28,162
2022-06-14	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Director	MExercise/Conversion	+25.8K sh	—	—	343,354
2022-06-14	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−25.8K sh	—	—	0
2022-06-13	NexImmune, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+61.7K sh	—	—	61,678
2022-06-02	NexImmune, Inc.P Purchase	Director	PPurchase	+20.7K sh	$2.22	+$46.1K	1,617,814
2022-06-01	NexImmune, Inc.P Purchase	Director	PPurchase	+40K sh	$2.35	+$94.2K	1,597,094
2022-05-31	NexImmune, Inc.P Purchase	Director	PPurchase	+39.3K sh	$2.19	+$85.9K	1,557,094
2022-05-17	CONTRAFECT CorpOptions (Right to Buy)A Award	Director	AAward	+42K sh	$3.35	+$141K	42,000
2022-03-23	NexImmune, Inc.P Purchase	Director	PPurchase	+10K sh	$2.67	+$26.7K	1,517,814
2022-03-22	NexImmune, Inc.P Purchase	Director	PPurchase	+30K sh	$2.41	+$72.3K	1,507,814
2022-03-21	NexImmune, Inc.P Purchase	Director	PPurchase	+30K sh	$2.14	+$64.1K	1,477,814
2022-03-18	NexImmune, Inc.P Purchase	Director	PPurchase	+30K sh	$2.11	+$63.2K	1,447,814
2021-12-21	NexImmune, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$5.17	+$259K	1,417,814
2021-12-21	NexImmune, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	155,900
2021-06-15	AVTXAvalo Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2021-06-14	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsA Award	Director	AAward	+25.8K sh	—	—	25,791
2021-06-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Director	MExercise/Conversion	+22.6K sh	—	—	317,563
2021-06-09	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−22.6K sh	—	—	0
2021-06-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD · Restricted Share UnitsM Exercise/Conversion	Director	MExercise/Conversion	−17.6K sh	—	—	0
2021-06-05	TEVATEVA PHARMACEUTICAL INDUSTRIES LTDM Exercise/Conversion	Director	MExercise/Conversion	+17.6K sh	—	—	294,998
2021-05-18	CONTRAFECT CorpOptions (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2021-02-17	NexImmune, Inc.C Conversion	Director	CConversion	+894K sh	—	—	894,036
2021-02-17	NexImmune, Inc.C Conversion	Director	CConversion	+800K sh	—	—	1,367,814
2021-02-17	NexImmune, Inc.C Conversion	Director	CConversion	+164K sh	—	—	1,058,444
2021-02-17	NexImmune, Inc.Series A Preferred StockC Conversion	Director	CConversion	−218K sh	—	—	0
2021-02-17	NexImmune, Inc.C Conversion	Director	CConversion	+82.2K sh	—	—	1,140,648
2021-02-17	NexImmune, Inc.C Conversion	Director	CConversion	+337K sh	—	—	1,478,013
2021-02-17	NexImmune, Inc.Series A3 Preferred StockC Conversion	Director	CConversion	−82.2K sh	—	—	0

Recent filings

Accepted (ET)
Jun 84
BARER SOL J0001193125-26-261715
SEC(opens sec.gov)
Jun 14
BARER SOL J0001193125-26-251384
SEC(opens sec.gov)
Jun 94
BARER SOL J0000950170-25-083706
SEC(opens sec.gov)
Jun 174
BARER SOL J0000950170-24-074001
SEC(opens sec.gov)
Jun 104
BARER SOL J0000950170-24-071062
SEC(opens sec.gov)
Aug 74
BARER SOL J0001209191-23-044769
SEC(opens sec.gov)
Jul 74
BARER SOL J0000950170-23-032245
SEC(opens sec.gov)
Jun 204
BARER SOL J0001209191-23-038217
SEC(opens sec.gov)
Apr 64
BARER SOL J0001209191-23-023681
SEC(opens sec.gov)
Mar 314
BARER SOL J0001209191-23-021889
SEC(opens sec.gov)

Companies

Address

C/O TEVA PHARMACEUTICAL INDUSTRIES LTD. 124 DVORA HANEVI'A ST.,

TEL AVIV, 6944020